---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-010257"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:25:36.130407+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bausch Health appoints Jean-Jacques Charhon as CFO, Aimee Lenar as EVP US Pharma

## Summary
- Jean-Jacques Charhon named CFO effective Aug 19, 2024; base salary $700K, target bonus 60%, equity grants ~$3M.
- Charhon receives one-time sign-on cash bonus of $300K and sign-on equity grant of $3.5M (50% RSUs, 50% PSUs).
- Interim CFO John Barresi returns to SVP, Controller role; granted $350K retention RSU award vesting over 3 years.
- Barresi's enhanced severance extended to Dec 31, 2025; bi-weekly $5K stipend extended to Sep 30, 2024.
- Aimee Lenar joined Jul 15, 2024 as EVP US Pharma, leading Salix, Neurology, Generics, Market Access.

## SEC filing metadata
- accession: 0000950103-24-010257
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/0000950103-24-010257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/dp214678_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-010257
- JSON: https://secwatch.observer/filing/0000950103-24-010257.json
- Plain text: https://secwatch.observer/filing/0000950103-24-010257.txt

## Key facts
- Executive change
  John S. Barresi changed role as Senior Vice President, Controller and Chief Accounting Officer at Bausch Health Companies Inc..
  - Action: will no longer act in this capacity and will continue
  - Role: Senior Vice President, Controller and Chief Accounting Officer
  source text: John S. Barresi, who has served as the Company’s interim Chief Financial Officer since October 2023, will no longer act in this capacity and will continue in his role as Senior Vice President, Controller and Chief Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/0000950103-24-010257-index.htm
- Executive change
  Jean-Jacques Charhon was appointed as Executive Vice President and Chief Financial Officer at Bausch Health Companies Inc..
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: On July 15, 2024, the Board of Directors (the “Board”) of Bausch Health Companies Inc. (the “Company”) appointed Jean-Jacques Charhon as the Company’s Executive Vice President and Chief Financial Officer, effective as of August 19, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/0000950103-24-010257-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.